World leader in innovative esthetic dental solutions selects clinivation WorldView as its most comprehensive, authoritative resource for building medical product submissions and registrations worldwide.
Framingham, MA, April 26, 2007 – clinivation, Inc. announced today that Nobel Biocare USA, Inc., subsidiary of Nobel Biocare, has selected clinivation WorldView™.
“We are delighted to add Nobel Biocare to our growing list of clinivation WorldView users,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With comprehensive, authoritative, and up-to-date regulatory intelligence, Nobel will be readily alerted of important updates to worldwide submission and approval processes,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Nobel Biocare
Nobel Biocare is a medical devices group and the world leader in esthetic dental solutions offering a wide range of innovative Crown & Bridge & Implant products, as well as training & education and clinically documented treatment concepts. Nobel Biocare has around 2000 employees worldwide with headquarters located in Zurich, Switzerland and Gothenburg, Sweden.
For more information, please visit http://www.nobelbiocare.com.
